Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation

Autor: Alban Todesco, Julien Grynblat, Kouamé Kan Firmin Akoumia, Damien Bonnet, Pedro Mendes‐Ferreira, Stéphane Morisset, Denis Chemla, Marilyne Levy, Mathilde Méot, Sophie‐Guiti Malekzadeh‐Milani, Birger Tielemans, Benoit Decante, Carine Vastel‐Amzallag, Paul Habert, Maria‐Rosa Ghigna, Marc Humbert, David Montani, David Boulate, Frédéric Perros

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 14 (2024)

Background The primary genetic risk factor for heritable pulmonary arterial hypertension is the presence of monoallelic mutations in the BMPR2 gene. The incomplete penetrance of BMPR2 mutations implies that additional triggers are necessary for pulmo

Externí odkaz: https://doaj.org/article/4520f0f27dce4d70ad92d5eac4842764

Identifying Potential Mutations Responsible for Cases of Pulmonary Arterial Hypertension

Autor: Egom EE, Moyou-Somo R, Essame Oyono JL, Kamgang R

Publikováno v: The Application of Clinical Genetics, Vol Volume 14, Pp 113-124 (2021)

Emmanuel Eroume-A Egom,1– 3 Roger Moyou-Somo,2 Jean Louis Essame Oyono,2 Rene Kamgang2 1Institut du Savoir Montfort (ISM), Hôpital Montfort, Ottawa, ON, Canada; 2Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medi

Externí odkaz: https://doaj.org/article/4074df92d1ef485abc1681b23e11ce42

Identifying Potential Mutations Responsible for Cases of Pulmonary Arterial Hypertension

Autor: René Kamgang, Jean Louis Essame Oyono, Roger Moyou-Somo, Emmanuel Eroume-A Egom

Publikováno v: The Application of Clinical Genetics

Pulmonary Arterial Hypertension (PAH) is a progressive and devastating disease for which there is an escalating body of genetic and related pathophysiological information on disease pathobiology. Nevertheless, the success to date in identifying susce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b11ee13ee7fa83ca0bb47f50e99c4049
http://europepmc.org/articles/PMC7958998

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Application of [18F]FLT-PET in pulmonary arterial hypertension: a clinical study in pulmonary arterial hypertension patients and unaffected bone morphogenetic protein receptor type 2 mutation carriers

Autor: Jurjan Aman, Marc C. Huisman, Anton Vonk Noordegraaf, Harm Jan Bogaard, Onno A. Spruijt, Ali Ashek, Liza Botros, Hans Harms, Lan Zhao, Frances S. de Man, Jelco Tramper, Samara M.A. Jansen

Publikováno v: Pulmonary Circulation, 11(3). University of Chicago Press
Pulmonary Circulation, Vol 11 (2021)
Botros, L, Jansen, S M A, Ashek, A, Spruijt, O A, Tramper, J, Noordegraaf, A V, Aman, J, Harms, H, de Man, F S, Huisman, M C, Zhao, L & Bogaard, H J 2021, ' Application of [18F]FLT-PET in pulmonary arterial hypertension: a clinical study in pulmonary arterial hypertension patients and unaffected bone morphogenetic protein receptor type 2 mutation carriers ', Pulmonary Circulation, vol. 11, no. 3 . https://doi.org/10.1177/20458940211028017
Pulmonary Circulation

Pulmonary arterial hypertension is a heterogeneous group of diseases characterized by vascular cell proliferation leading to pulmonary vascular remodelling and ultimately right heart failure. Previous data indicated that 3′-deoxy-3′-[18F]-fluorot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f32f60b4082090358aa6f4c44f190e
https://doi.org/10.1177/20458940211028017